Voyager Therapeutics Inc (NASDAQ: VYGR) stock suffered a major decline of -21.0% on 2/11/25. The shares closed at $4.20. Moreover, trading volume in this decline was exceptionally high at 369% of normal. The stock has been extremely weak relative to the market over the last nine months and has declined -21.1% during the last week.
Current PriceTarget Research Rating
Voyager Therapeutics has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing inconsistent signals. Voyager Therapeutics has a neutral Appreciation Score of 52 but a poor Power Rating of 19, leading to the Negative Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment